New device could get heart patients walking faster after procedure

NCT ID NCT07414121

Recruiting now Symptom relief Sponsor: Asklepios proresearch Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a special closure device (VASCADE MVP) to stop bleeding after a heart ablation for atrial fibrillation. The goal is to see if it helps patients get up and walk sooner compared to standard manual compression. One hundred adults undergoing ablation will be randomly assigned to either the device or standard care, and recovery time will be measured.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: VASCADE MVP vascular closure device
What this could lead to: If successful, this device could help patients get out of bed faster after heart ablation procedures, reducing discomfort and hospital stay.
What could go wrong: This is a small early-stage study (100 patients) focused on recovery speed, not on treating atrial fibrillation itself. The device may not prove safer or more effective than standard methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION

Contacts and locations

Locations

Asklepios Klinik Altona
RECRUITING

Hamburg, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.